Prevention of Breakthrough Varicella and Outbreaks by Two Dose Vaccination
DOI:
https://doi.org/10.37591/rrjoi.v4i3.1243Abstract
Among viral infections, one of the known human herpes viruses, Varicella-Zoster Virus (VZV) causes latent infection. The VZV causes two distinct diseases, varicella (chickenpox) and after latency shingles (herpes zoster). Although safe and effective vaccine is available, it is not widely used in many geographic areas mainly because of non-inclusion in the routine immunization schedule. Over the years, many countries have reported more than 90% reduction in number of varicella infections mainly due to vaccination. In developing countries estimated 15–16 cases per thousand are reported of which 2–4% develop complications. An effective surveillance to detect cases of varicella and introduction of vaccination are essential to control and prevent varicella infections. Since humans are only reservoir for this virus, it is possible to eradicate this disease by effective vaccination program. Sometimes it is possible to get chicken pox with wild type of Varicella-Zoster virus after varicella vaccination and is termed as modified or breakthrough varicella infection. A coverage of two doses provides maximum protection. A number of studies conducted across the globe emphasis the need to implement two vaccine doses to maintain a high level of immunity, to prevent breakthrough varicella and epidemics.
Keywords: Varicella-Zoster virus, chicken pox, shingles, breakthrough varicella, vaccination, infection, varicella vaccine
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
